Skip to Content

Join the 'Crohn's Disease' group to help and get support from people like you.

Crohn's Disease Support Group

Related terms: Crohns

Summary

Our support group for Crohn's Disease has 208 questions and 245 members. Updated 5 Apr 2018.

Popular Questions

View more questions...

Further Information

Related Condition Support Groups

Crohn's Disease - Maintenance, Crohn's Disease - Acute, Inflammatory Bowel Disease

Related Drug Support Groups

Topamax, Cipro, Humira, ciprofloxacin, topiramate, Remicade, cholestyramine, Asacol, Imuran, view more... hyoscyamine, Stelara, sulfasalazine, Pentasa, budesonide, Lialda, cyclosporine, Cimzia, tacrolimus, azathioprine, rifaximin, Entocort EC, Questran, Entyvio, Apriso, Prevalite, mesalamine, mycophenolate mofetil, Canasa, infliximab, Levsin, Neoral, adalimumab, Levsin SL, Asacol HD, Symax Duotab, balsalazide, HyoMax, Hyosyne, Anaspaz, vedolizumab, Cholestyramine Light, Inflectra, Topamax Sprinkle, Symax FasTab, HyoMax SL, HyoMax SR, certolizumab, ustekinumab, Hyosol, Amjevita, Renflexis, Cyltezo, Sandimmune, Gengraf, Ixifi, Questran Light, Rowasa, Azasan, Locholest Light, Cipro XR, Cipro IV, FIV-ASA, Oscimin, Gastrosed, Salofalk, Ed-Spaz, Topiragen, Mesasal Enteric Coated, Colidrops, Colazal, Cystospaz-M, Levsinex SR, Hyospaz, Symax SL, A-Spas S / L, Donnamar, Cystospaz, Symax SR, IB-Stat, Levbid, Spasdel, Canasa Pac, A-Spaz, HyoMax FT, NuLev, Levsinex, HyoMax DT, Locholest

Related Condition Guides

Search this Group

Latest News

FDA Approves Ixifi (infliximab-qbtx), a Biosimilar to Remicade

December 13, 2017 – Pfizer Inc. (NYSE:PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Ixifi (PF-06438179, infliximab-qbtx), a chimeric ...

Read more news...

Latest Questions

View more questions...

Top Group Members

Marvell
14,356 total answers
suzanne66
11,207 total answers
MrsCJ
16 total answers
mittykitty
14 total answers
ChelleKay
170 total answers
coloresue
1,080 total answers

View all 245 members...

Ask a Question